Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 3, 2014, Pages 751-757

  Sancakdar, Enver ^a   Güven, Ahmet Sami ^a   Uysal, Elif Bilge ^a   Kaya, Ali ^a   Deveci, Köksal ^a   Karapinar, Hekim ^a   Akkar, Ismail ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Sivas Devlet Hastanesi   (Turkey)

Author keywords

Crimean congo hemorrhagic fever; ET 1; IL 10; IL 12; Th2

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; D DIMER; ENDOTHELIN 1; FIBRINOGEN; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ARTICLE; BLEEDING; CHILD; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; CRIMEAN CONGO HEMORRHAGIC FEVER; DIARRHEA; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATOMEGALY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MELENA; MYALGIA; NAUSEA AND VOMITING; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PETECHIA; PHARYNGITIS; PROTHROMBIN TIME; PURPURA; SCHOOL CHILD; SOMNOLENCE; SPLENOMEGALY; TH1 CELL; TH2 CELL; THROMBOCYTE COUNT; WEAKNESS;

EID: 84897553902     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004; 64: 145-160.
2. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, McGillivray GM, Erasmus MJ, Searle LA and Gill DE. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 1987; 36: 120-132.
3. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6: 203-214.
4. Papa A, Bino S, Velo E, Harxhi A, Kota M and Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006; 36: 272-276.
5. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S and Avsic-Zupanc T. Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin Vaccine Immunol 2010; 17: 1086-1093.
6. Ergonul O, Tuncbilek S, Baykam N, Celikbas A and Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006; 193: 941-944.
7. Bente DA, Alimonti JB, Shieh WJ, Camus G, Stroher U, Zaki S and Jones SM. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol 2010; 84: 11089-11100.
8. Yanagisawa M, Kurihara H, Kimura S, Goto K and Masaki T. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 1988; 6: S188-191.
9. Magder S and Cernacek P. Role of endothelins in septic, cardiogenic, and hemorrhagic shock. Can J Physiol Pharmacol 2003; 81: 635-643.
10. Deveci K, Oflaz MB, Sancakdar E, Uysal EB, Guven AS, Kaya A, Alkan F and Cevit O. Evaluation of the serum levels of soluble IL-2 receptor and endothelin-1 in children with Crimean-Congo hemorrhagic fever. APMIS 2013; [Epub ahead of print].
11. Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, Pavlidou V, Velo E, Cahani G, Hajdini M, Pilaca A, Harxhi A and Antoniadis A. Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis 2002; 21: 603-606.
12. Papa A, Dalla V, Papadimitriou E, Kartalis GN and Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin Microbiol Infect 2010; 16: 843-847.
13. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH and Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11 Suppl 4: S794-800.
14. Yilmaz G, Koksal I, Topbas M, Yilmaz H and Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 2010; 47: 361-365.
15. Cevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A and Akinci E. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12: 374-379.
16. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Rothman AL and Ennis FA. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999; 59: 329-334.
17. Ter Meulen J, Sakho M, Koulemou K, Magassouba N, Bah A, Preiser W, Daffis S, Klewitz C, Bae HG, Niedrig M, Zeller H, Heinzel-Gutenbrunner M, Koivogui L and Kaufmann A. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis 2004; 190: 1821-1827.
18. Chen HC, Hofman FM, Kung JT, Lin YD and Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007; 81: 5518-5526.
19. Lukashevich IS, Tikhonov I, Rodas JD, Zapata JC, Yang Y, Djavani M and Salvato MS. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol 2003; 77: 1727-1737.
20. Ozsurekci Y, Arasli M, Karadag Oncel E, Caglayik DY, Kaya A, Icagasioglu FD, Engin A, Korukluoglu G, Elaldi N and Ceyhan M. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? J Med Virol 2013; 85: 1955-1959.
21. Mihara M, Hashizume M, Yoshida H, Suzuki M and Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2012; 122: 143-159.
22. Petrache I, Birukova A, Ramirez SI, Garcia JG and Verin AD. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 2003; 28: 574-581.
23. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol 2012; 2: 215-220.
24. Watford WT, Moriguchi M, Morinobu A and O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-368.
25. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K and Geginat J. Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21: 331-344.